FINANCIAL ADVOCATES INVESTMENT MANAGEMENT – Pfizer Inc. Transaction History
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT portfolio value:
$2.10M
portfolio value
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT quarter portfolio value change:
-16.54%
quarter
Pfizer Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.82% | 1.31K shares | -349K | $43.76 | 48.05K |
| Q2 2022 | share | Decrease | -11.76% | -6.23K shares | -290K | $52.43 | 46.73K |
| Q1 2022 | share | Decrease | -2.03% | -1.1K shares | -452K | $51.77 | 52.96K |
| Q4 2021 | share | Decrease | -0.49% | -265 shares | 856K | $58.4 | 54.06K |
| Q3 2021 | share | Decrease | -14.10% | -8.92K shares | -140K | $42.63 | 54.32K |
| Q2 2021 | share | Decrease | -1.57% | -1.00K shares | 149K | $38.46 | 63.25K |
| Q1 2021 | share | Decrease | -2.23% | -1.46K shares | -91K | $35.24 | 64.25K |
| Q4 2020 | share | Increase | +2.54% | 1.62K shares | 187K | $35.41 | 65.72K |
| Q3 2020 | share | Increase | +9.98% | 5.81K shares | 424K | $33.15 | 64.1K |
| Q2 2020 | share | Increase | +6.87% | 3.74K shares | 119K | $29.25 | 58.28K |
| Q1 2020 | share | Decrease | -27.59% | -20.78K shares | -1.11M | $28.9 | 54.54K |
| Q4 2019 | share | Increase | +0.48% | 362 shares | 243K | $34.34 | 75.32K |
| Q3 2019 | share | Increase | +26.87% | 15.87K shares | 127K | $31.19 | 74.95K |
| Q2 2019 | share | Increase | +3.64% | 2.07K shares | 132K | $37.25 | 59.08K |
| Q1 2019 | share | Decrease | -0.03% | -15 shares | -64K | $36.2 | 57.00K |
| Q4 2018 | share | Decrease | -14.03% | -9.30K shares | -412K | $36.89 | 57.02K |
| Q3 2018 | share | Increase | +12.20% | 7.21K shares | 735K | $36.96 | 66.32K |
| Q2 2018 | share | Decrease | -12.25% | -8.24K shares | -230K | $30.17 | 59.11K |
| Q1 2018 | share | Increase | +15.38% | 8.98K shares | 262K | $29.23 | 67.36K |
| Q4 2017 | share | Increase | 0.00% | 58.38K shares | 2.00M | $29.56 | 58.38K |